CTOs on the Move

California Imaging Svc

www.cisxray.com

 
California Imaging Svc is a Fairfield, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.cisxray.com
  • 499 Edison Ct Ste C
    Fairfield, CA USA 94534
  • Phone: 707.864.6704

Executives

Name Title Contact Details

Similar Companies

Careage Hills

Careage Hills is a Cherokee, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cambia Health

Cambia Health Solutions is a family of companies headquartered in Portland, Oregon, working to create a person-focused and economically sustainable health care system. Through our health plans, innovative technology and strategic investments, we are delivering consumer-centric solutions that: • help people achieve better health and well-being • make health care more available, affordable and accessible • are easily understood by everyone We put people at the heart of everything we do. Our company reaches more than 70 million Americans nationwide, including more than two million people in the Pacific Northwest who are enrolled in our regional health plans.

VTS Medical Systems

VTS Medical Systems is a Melville, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Five Seasons Sports Club

Five Seasons Sports Club is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.